N
Neuphoria Therapeutics Inc
NASDAQ:NEUP
Neuphoria Therapeutics Inc
NASDAQ:NEUP
Price:
4.78
USD
1.27%
Market Closed
Market Cap:
$25.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Neuphoria Therapeutics Inc
NASDAQ:NEUP
|
US |
|
V
|
Vinyl Chemicals India Ltd
NSE:VINYLINDIA
|
IN |
|
American Green Inc
OTC:ERBB
|
US |
|
Code Rebel Corp
OTC:CDRBQ
|
US |
|
I
|
Indigo Star Holdings Ltd
HKEX:8373
|
SG |
|
T
|
Tempur Sealy International Inc
NYSE:SGI
|
US |
|
UTL Industries Ltd
BSE:500426
|
IN |
|
E
|
Erin Ventures Inc
XTSX:EV
|
CA |
|
Cerebra Integrated Technologies Ltd
NSE:CEREBRAINT
|
IN |
|
Wintrust Financial Corp
NASDAQ:WTFC
|
US |
|
V
|
Vanov Holdings Company Ltd
HKEX:2260
|
CN |
|
Tenfu (Cayman) Holdings Co Ltd
HKEX:6868
|
CN |
|
H
|
Hua Medicine
HKEX:2552
|
CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
CN |
|
3
|
37 Capital Inc
CNSX:JJJ.X
|
CA |
|
Pool Corp
NASDAQ:POOL
|
US |
|
Sabre Insurance Group PLC
LSE:SBRE
|
UK |
Cash Flow Statement
Cash Flow Statement
Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc
Currency: USD
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
0
|
0
|
0
|
0
|
(21)
|
0
|
(15)
|
(16)
|
(18)
|
(7)
|
(0)
|
(9)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
1
|
0
|
2
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
1
|
0
|
(1)
|
(4)
|
(5)
|
(5)
|
0
|
7
|
4
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
1
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(6)
|
(14)
|
(16)
|
(12)
|
5
|
1
|
1
|
0
|
9
|
9
|
(0)
|
2
|
(1)
|
|
| Cash from Operating Activities |
(6)
N/A
|
(14)
-150%
|
(16)
-12%
|
(12)
+21%
|
(15)
-18%
|
(18)
-23%
|
(15)
+18%
|
(19)
-30%
|
(13)
+31%
|
(2)
+87%
|
0
N/A
|
1
+827%
|
(2)
N/A
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
0
+28%
|
0
-71%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
33
|
51
|
24
|
8
|
4
|
6
|
15
|
15
|
8
|
9
|
2
|
5
|
19
|
|
| Net Issuance of Debt |
(9)
|
(8)
|
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
(3)
|
(4)
|
(2)
|
0
|
(1)
|
0
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
24
N/A
|
40
+69%
|
20
-51%
|
6
-71%
|
4
-31%
|
7
+84%
|
15
+113%
|
15
-2%
|
8
-49%
|
9
+15%
|
2
-82%
|
5
+228%
|
20
+295%
|
|
| Change in Cash | ||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Net Change in Cash |
18
N/A
|
26
+44%
|
4
-86%
|
(7)
N/A
|
(11)
-59%
|
(11)
-1%
|
1
N/A
|
(4)
N/A
|
(6)
-38%
|
7
N/A
|
2
-78%
|
6
+247%
|
18
+221%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
(6)
N/A
|
(14)
-150%
|
(16)
-12%
|
(12)
+21%
|
(15)
-18%
|
(18)
-23%
|
(15)
+18%
|
(19)
-30%
|
(13)
+31%
|
(2)
+87%
|
0
N/A
|
1
+827%
|
(2)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
